# FDA Inspection 580664 - Octapharma AB - January 29, 2009

Source: https://www.globalkeysolutions.net/records/fda_inspections/octapharma-ab/aecdcdae-81fa-4620-9ef5-96c6d77149d6/
Source feed: FDA_Inspections

> FDA Inspection 580664 for Octapharma AB on January 29, 2009. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 580664
- Company Name: Octapharma AB
- Inspection Date: 2009-01-29
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1218250 - 2023-09-19](https://www.globalkeysolutions.net/api/records/fda_inspections/octapharma-ab/3645f477-d675-40fc-90b8-3704a595408d/)
- [FDA Inspection 1070173 - 2018-09-28](https://www.globalkeysolutions.net/api/records/fda_inspections/octapharma-ab/d1bd9bce-fbba-4979-be9f-74a49e7eed87/)
- [FDA Inspection 894095 - 2014-04-28](https://www.globalkeysolutions.net/api/records/fda_inspections/octapharma-ab/b353da3f-7e1b-492d-8bed-ece62fb5761e/)
- [FDA Inspection 783783 - 2012-01-19](https://www.globalkeysolutions.net/api/records/fda_inspections/octapharma-ab/1a09a3bb-de0f-4a67-b7be-e990f830f4fa/)
- [FDA Inspection 710676 - 2011-01-20](https://www.globalkeysolutions.net/api/records/fda_inspections/octapharma-ab/e46fa3b2-794a-456e-97d5-2b973b8e1194/)

Company: https://www.globalkeysolutions.net/companies/octapharma-ab/5a456872-4ca6-4418-b006-6e7e219ec262

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d